/Investor DB

GENERAL INCEPTION — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Simbiosyssimbiosys.comin𝕏Jan 2025SEC filingmedium confidence

SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

Joe Peterson(Co-founder)John Cole(Co-founder)Tushar Pandey(Co-founder)inStacey Stevens(Executive Officer, Director)in

BoardLucy Coassin(Director)

Board seatVikram Chaudhery· per SEC Form D · $8M raise · filed Jan 2025

Co-investorsAV8 VenturesGenoa VenturesKleinmuntz AssociatesNorthpond Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.